Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Front Immunol. 2023 Oct 25;14:1264093. doi: 10.3389/fimmu.2023.1264093. eCollection 2023.
Front Immunol. 2023.
PMID: 38022675
Free PMC article.
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.
De Azevedo J, Mourtada J, Bour C, Devignot V, Schultz P, Borel C, Pencreach E, Mellitzer G, Gaiddon C, Jung AC.
De Azevedo J, et al. Among authors: bour c.
Cells. 2022 Sep 14;11(18):2866. doi: 10.3390/cells11182866.
Cells. 2022.
PMID: 36139440
Free PMC article.
Item in Clipboard
Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells.
Reita D, Bour C, Benbrika R, Groh A, Pencreach E, Guérin E, Guenot D.
Reita D, et al. Among authors: bour c.
Cancers (Basel). 2019 Oct 17;11(10):1581. doi: 10.3390/cancers11101581.
Cancers (Basel). 2019.
PMID: 31627299
Free PMC article.
Item in Clipboard
Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.
Romain B, Benbrika-Nehmar R, Marisa L, Legrain M, Lobstein V, Oravecz A, Poidevin L, Bour C, Freund JN, Duluc I, Guenot D, Pencreach E.
Romain B, et al. Among authors: bour c.
Oncotarget. 2017 Jun 13;8(24):38351-38366. doi: 10.18632/oncotarget.16323.
Oncotarget. 2017.
PMID: 28418886
Free PMC article.
Item in Clipboard
Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction.
Job S, Reyniès A, Heller B, Weiss A, Guérin E, Macabre C, Ledrappier S, Bour C, Wasylyk C, Etienne-Selloum N, Brino L, Gaiddon C, Wasylyk B, Jung AC.
Job S, et al. Among authors: bour c.
Cancers (Basel). 2019 Jun 8;11(6):795. doi: 10.3390/cancers11060795.
Cancers (Basel). 2019.
PMID: 31181806
Free PMC article.
Item in Clipboard
Cite
Cite